Neovasc Inc. – TSX:NVCN.TO
Neovasc stock price today
Neovasc stock price monthly change
Neovasc stock price quarterly change
Neovasc stock price yearly change
Neovasc key metrics
Market Cap | 110.78M |
Enterprise value | 91.66M |
P/E | -1.98 |
EV/Sales | 29.46 |
EV/EBITDA | -2.90 |
Price/Sales | 35.42 |
Price/Book | 3.92 |
PEG ratio | -0.02 |
EPS | N/A |
Revenue | 3.80M |
EBITDA | -37.06M |
Income | -47.35M |
Revenue Q/Q | 91.39% |
Revenue Y/Y | 49.36% |
Profit margin | -1077.28% |
Oper. margin | -855.35% |
Gross margin | 76.74% |
EBIT margin | -855.35% |
EBITDA margin | -974.19% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNeovasc stock price history
Neovasc stock forecast
Neovasc financial statements
| Mar 2022 | 610.74K | -13.87M | -2272.22% |
|---|---|---|---|
| Jun 2022 | 818.06K | -9.77M | -1194.36% |
| Sep 2022 | 923.31K | -9.86M | -1068.17% |
| Dec 2022 | 1.45M | -13.84M | -952.63% |
| Mar 2022 | 60047330 | 16.27M | 27.1% |
|---|---|---|---|
| Jun 2022 | 51929185 | 16.36M | 31.51% |
| Sep 2022 | 44576719 | 16.51M | 37.05% |
| Dec 2022 | 38729112 | 22.89M | 59.1% |
| Mar 2022 | -6.98M | 0 | -393.41K |
|---|---|---|---|
| Jun 2022 | -6.26M | -48.32K | -221.59K |
| Sep 2022 | -6.29M | -4.14K | -74.73K |
| Dec 2022 | -5.39M | 0 | -72.54K |
Neovasc alternative data
| Aug 2023 | 49 |
|---|---|
| Sep 2023 | 49 |
| Oct 2023 | 49 |
| Nov 2023 | 49 |
| Dec 2023 | 49 |
| Jan 2024 | 49 |
| Feb 2024 | 49 |
| Apr 2024 | 49 |
| May 2024 | 49 |
| Jun 2024 | 49 |
| Jul 2024 | 49 |
Neovasc other data
| Insider | Compensation |
|---|---|
Mr. Fredericus A. Colen (1952) Pres, Chief Executive Officer & Director | $664,970 |
Mr. William Reed Little (1972) Chief Operating Officer | $452,250 |
Mr. Christopher Clark B.A., C.A., BA (Honours), PgD, CA (1972) Chief Financial Officer & Corporation Sec. | $400,460 |
Mr. John Christopher Panton (1967) Chief Quality Officer | $238,220 |
-
What's the price of Neovasc stock today?
One share of Neovasc stock can currently be purchased for approximately $0.58.
-
When is Neovasc's next earnings date?
Unfortunately, Neovasc's (NVCN.TO) next earnings date is currently unknown.
-
Does Neovasc pay dividends?
No, Neovasc does not pay dividends.
-
How much money does Neovasc make?
Neovasc has a market capitalization of 110.78M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 49.37% to 3.81M US dollars.
-
What is Neovasc's stock symbol?
Neovasc Inc. is traded on the TSX under the ticker symbol "NVCN.TO".
-
What is Neovasc's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Neovasc?
Shares of Neovasc can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Neovasc's key executives?
Neovasc's management team includes the following people:
- Mr. Fredericus A. Colen Pres, Chief Executive Officer & Director(age: 73, pay: $664,970)
- Mr. William Reed Little Chief Operating Officer(age: 53, pay: $452,250)
- Mr. Christopher Clark B.A., C.A., BA (Honours), PgD, CA Chief Financial Officer & Corporation Sec.(age: 53, pay: $400,460)
- Mr. John Christopher Panton Chief Quality Officer(age: 58, pay: $238,220)
-
How many employees does Neovasc have?
As Jul 2024, Neovasc employs 49 workers.
-
When Neovasc went public?
Neovasc Inc. is publicly traded company for more then 11 years since IPO on 23 Jun 2014.
-
What is Neovasc's official website?
The official website for Neovasc is neovasc.com.
-
Where are Neovasc's headquarters?
Neovasc is headquartered at 13562 Maycrest Way, Richmond, BC.
-
How can i contact Neovasc?
Neovasc's mailing address is 13562 Maycrest Way, Richmond, BC and company can be reached via phone at +60 4 270 4344.
Neovasc company profile:
Neovasc Inc.
neovasc.comTSX
49
Medical - Devices
Healthcare
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Richmond, BC V6V 2J7
:
:
:
